These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 9365001)

  • 1. 4G/5G polymorphism in the promoter region of the PAI-1 gene is not a risk factor for familial myocardial infarction in subjects over 45 years.
    Burzotta F; Di Castelnuovo A; Amore C; D'Orazio A; Donati MB; Iacoviello L
    Thromb Haemost; 1997 Oct; 78(4):1294-5. PubMed ID: 9365001
    [No Abstract]   [Full Text] [Related]  

  • 2. Relationship between gene polymorphism of the PAI-1 promoter and myocardial infarction.
    Fu L; Jin H; Song K; Zhang C; Shen J; Huang Y
    Chin Med J (Engl); 2001 Mar; 114(3):266-9. PubMed ID: 11780311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The 4G/5G polymorphism in the plasminogen activator inhibitor-1 gene is not associated with myocardial infarction.
    Doggen CJ; Bertina RM; Cats VM; Reitsma PH; Rosendaal FR
    Thromb Haemost; 1999 Jul; 82(1):115-20. PubMed ID: 10456464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The 4G/5G polymorphism of PAI-1 promoter gene and the risk of myocardial infarction: a meta-analysis.
    Iacoviello L; Burzotta F; Di Castelnuovo A; Zito F; Marchioli R; Donati MB
    Thromb Haemost; 1998 Dec; 80(6):1029-30. PubMed ID: 9869181
    [No Abstract]   [Full Text] [Related]  

  • 5. 4G/5G polymorphism of PAI-1 gene promoter and fibrinolytic capacity in patients with deep vein thrombosis.
    Sartori MT; Wiman B; Vettore S; Dazzi F; Girolami A; Patrassi GM
    Thromb Haemost; 1998 Dec; 80(6):956-60. PubMed ID: 9869167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PAI-1 4G/5G insertion/deletion promoter polymorphism and microvascular complications in type 2 diabetes mellitus.
    Funk M; Endler G; Exner M; Marculescu R; Endler L; Abrahamian H; Mauler H; Grimm A; Raith M; Mannhalter C; Prager R; Irsigler K; Wagner OF
    Wien Klin Wochenschr; 2005 Oct; 117(19-20):707-10. PubMed ID: 16416371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A common 4G allele in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene as a risk factor for pulmonary embolism and arterial thrombosis in hereditary protein S deficiency.
    Zöller B; García de Frutos P; Dahlbäck B
    Thromb Haemost; 1998 Apr; 79(4):802-7. PubMed ID: 9569196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic effect of thrombomodulin promoter -33G/A polymorphism and smoking on the onset of acute myocardial infarction.
    Li YH; Chen JH; Tsai WC; Chao TH; Guo HR; Tsai LM; Wu HL; Shi GY
    Thromb Haemost; 2002 Jan; 87(1):86-91. PubMed ID: 11848462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The 4G/5G sequence polymorphism in the promoter of plasminogen activator inhibitor-1 (PAI-1) gene: relationship to plasma PAI-1 level in venous thromboembolism.
    Stegnar M; Uhrin P; Peternel P; Mavri A; Salobir-Pajnic B; Stare J; Binder BR
    Thromb Haemost; 1998 May; 79(5):975-9. PubMed ID: 9609232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasminogen activator inhibitor-1 (PAI-1) 4G/5G polymorphism, coronary thrombosis, and myocardial infarction in middle-aged Finnish men who died suddenly.
    Mikkelsson J; Perola M; Wartiovaara U; Peltonen L; Palotie A; Penttilä A; Karhunen PJ
    Thromb Haemost; 2000 Jul; 84(1):78-82. PubMed ID: 10928474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C-reactive protein is directly related to plasminogen activator inhibitor type 1 (PAI-1) levels in diabetic subjects with the 4G allele at position -675 of the PAI-1 gene.
    Testa R; Bonfigli AR; Sirolla C; Marra M; Boemi M; Mari D; Sacchi E; Dolci A; Catalano A; Procopio A; Ceriello A
    Nutr Metab Cardiovasc Dis; 2008 Mar; 18(3):220-6. PubMed ID: 17433639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The 4G4G genotype of the plasminogen activator inhibitor 4G/5G gene polymorphism is associated with coronary atherosclerosis in patients at high risk for this disease.
    Gardemann A; Lohre J; Katz N; Tillmanns H; Hehrlein FW; Haberbosch W
    Thromb Haemost; 1999 Sep; 82(3):1121-6. PubMed ID: 10494775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increase in plasma plasminogen activators inhibitor type 1 concentration after fibrinolytic treatment in patients with acute myocardial infarction is associated with 4G/5G polymorphism of PAI-1 gene.
    Mlynarska A; Waszyrowski T; Kasprzak JD
    J Thromb Haemost; 2006 Jun; 4(6):1361-6. PubMed ID: 16706983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The study of PAI-1 promotor region gene polymorphism in cerebrovascular disease].
    Zhang C; Li J; Li L; Luo B
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2001 Oct; 18(5):383-7. PubMed ID: 11592048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasminogen activator inhibitor -1 gene 4G/5G polymorphism in patients with breast cancer.
    Eroglu A; Ulu A; Cam R; Akar N
    J BUON; 2006; 11(4):481-4. PubMed ID: 17309181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of 4G/5G polymorphism in PAI1 promoter with PAI1 level in deep vein thrombosis.
    Chen YL; Zhang JX; Wang PX; Cui RZ; Zhao FM; Mao YM; Li JY; Bi YY; Li H
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Dec; 22(6):624-7. PubMed ID: 16331557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genotype frequency of plasminogen activator inhibitor-1 (PAI-1) 4G/5G polymorphism in healthy Japanese males and its relation to PAI-1 levels.
    Matsubara Y; Murata M; Isshiki I; Watanabe R; Zama T; Watanabe G; Watanabe K; Ikeda Y
    Int J Hematol; 1999 Jan; 69(1):43-7. PubMed ID: 10641442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PAI-1 Gene 4G/5G polymorphism and risk of type 2 diabetes in a population-based sample.
    Meigs JB; Dupuis J; Liu C; O'Donnell CJ; Fox CS; Kathiresan S; Gabriel SB; Larson MG; Yang Q; Herbert AG; Wilson PW; Feng D; Tofler GH; Cupples LA
    Obesity (Silver Spring); 2006 May; 14(5):753-8. PubMed ID: 16855181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The influences of genetic and environmental factors on plasma plasminogen activator inhibitor-1 levels in patients with essential hypertension].
    Song Y; Xu W; Chen Y; Che L; Wang Q; Zhou X; Wu J
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 1999 Dec; 16(6):374-6. PubMed ID: 10581347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regular exercise, plasminogen activator inhibitor-1 (PAI-1) activity and the 4G/5G promoter polymorphism in the PAI-1 gene.
    Väisänen SB; Humphries SE; Luong LA; Penttilä I; Bouchard C; Rauramaa R
    Thromb Haemost; 1999 Sep; 82(3):1117-20. PubMed ID: 10494774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.